Literature DB >> 15757078

The new definition of myocardial infarction--can we use it?

Stefan Agewall1, Christian Löwbeer.   

Abstract

BACKGROUND: A joint committee of the European Society of Cardiology and the American College of Cardiology (ESC/ACC) recently redefined myocardial infarction. HYPOTHESIS: The objective of this study was to examine the outcome of diagnoses from more than 500 patients admitted to a university hospital coronary care unit (CCU), when the ESC/ACC committee cut-off levels were compared with the Swedish diagnostic criteria for acute myocardial infarction (MI), comparable with everyday practice in most countries.
METHODS: Creatine kinase-MB, troponin I, and troponin T were measured in 525 patients admitted consecutively to the CCU, Huddinge University Hospital, with possible myocardial ischemia lasting <12 h before arrival.
RESULTS: The ESC/ACC definition of MI increased the number of MIs by 3-32% compared with the number achieved when Swedish diagnostic criteria for acute MI were used. A significant number of patients with elevated cardiac enzymes presented with acute heart failure, tachycardia, pulmonary embolism, and sepsis as initial symptom.
CONCLUSIONS: In this study of more than 500 patients with possible myocardial ischemia admitted consecutively to the CCU at a university hospital, the ESC/ACC definition of MI increased the number of MIs by 3-32% compared with the number achieved when Swedish diagnostic criteria for acute MI were used. A majority of the patients identified with ESC/ACC cut-off levels presented with myocardial ischemia as the primary symptom, whereas many of the other patients had acute heart failure and tachycardia as initial symptom. It is unclear whether patients in this latter group should be labelled as having MI; there are no clinical studies providing guidance in this situation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757078      PMCID: PMC6654659          DOI: 10.1002/clc.4960280207

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  19 in total

1.  Comparison of cardiac troponin I measurements on whole blood and plasma on the Stratus CS analyzer and comparison with AxSYM.

Authors:  J P Chapelle; M C Aldenhoff; L Pierard; J Gielen
Journal:  Clin Chem       Date:  2000-11       Impact factor: 8.327

2.  Rapid measurement of cardiac markers on Stratus CS.

Authors:  S Altinier; M Mion; A Cappelletti; M Zaninotto; M Plebani
Journal:  Clin Chem       Date:  2000-07       Impact factor: 8.327

3.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.

Authors:  D A Morrow; C P Cannon; N Rifai; M J Frey; R Vicari; N Lakkis; D H Robertson; D A Hille; P T DeLucca; P M DiBattiste; L A Demopoulos; W S Weintraub; E Braunwald
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

4.  Early statin treatment following acute myocardial infarction and 1-year survival.

Authors:  U Stenestrand; L Wallentin
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

5.  Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

Authors:  Per Venge; B o Lagerqvist; Erik Diderholm; Bertil Lindahl; Lars Wallentin
Journal:  Am J Cardiol       Date:  2002-05-01       Impact factor: 2.778

6.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

7.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

8.  Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.

Authors:  D A Morrow; N Rifai; M J Tanasijevic; D R Wybenga; J A de Lemos; E M Antman
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

9.  Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy.

Authors:  B Lindahl; E Diderholm; B Lagerqvist; P Venge; L Wallentin
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

10.  The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes.

Authors:  Mark A Meier; Wisam H Al-Badr; Jeanna V Cooper; Eva M Kline-Rogers; Dean E Smith; Kim A Eagle; Rajendra H Mehta
Journal:  Arch Intern Med       Date:  2002-07-22
View more
  1 in total

1.  The one year incidence of postoperative myocardial infarction in an orthopedic population.

Authors:  M K Urban; K Jules-Elysee; C Loughlin; W Kelsey; E Flynn
Journal:  HSS J       Date:  2007-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.